Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group.

Mednet Member

Pediatric Hematology/Oncology · Baylor College of Medicine

Great question. The answer is kind of. The COG studies AAML03P1 and AAML0531 gave 5 chemotherapy cycles to patients who did not go to transplant in first remission, but we know that some patients did not get the 5th cycle. As you suggested, most of the time the reason for stopping after 4 cycles was...